Thus, Wisconsin recently launched a project entitled “Assessing the Added Value of Whole Genome Sequencing in Cystic Fibrosis Newborn Screening” to address the hypothesis that identifying non-CFTR genetic variants in individual patients could enlighten therapeutic decision-making [58]. Here, CFTR is linked to cystic fibrosis.